Image pharmaphorum Editor Views & Analysis Coronavirus pharma news roundup - 07/08/20 Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Views & Analysis Tackling multimorbidity through collaboration As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems. Views & Analysis Preparing for an influx of cell and gene therapy approvals Cell and gene therapies offer some of the most groundbreaking advancements in patient care the pharma industry has ever seen. Views & Analysis Coronavirus pharma news roundup – 31/07/20 Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues. Load more results
Views & Analysis Coronavirus pharma news roundup - 07/08/20 Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales.
Views & Analysis Tackling multimorbidity through collaboration As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems.
Views & Analysis Preparing for an influx of cell and gene therapy approvals Cell and gene therapies offer some of the most groundbreaking advancements in patient care the pharma industry has ever seen.
Views & Analysis Coronavirus pharma news roundup – 31/07/20 Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.